BPC-157 Injection — lifestyle
    Recovery & RepairTendons & LigamentsGut Support
    INJECTIONComing soon

    2 mg/mL · 5 mL vial

    BPC-157 Injection

    For the men whose recovery has stopped keeping pace with their training.

    • Studied in the repair of tendon, ligament, muscle, and gut tissue
    • Subcutaneous injection, typically once daily
    • Single-ingredient, compounded by a licensed U.S. pharmacy

    The BPC-157 protocol will soon be available for purchase.

    Join the waitlist and we'll email you when ordering opens.

    Unsubscribe at any time.

    Verify Approval for www.edgerx.orgA4M — Medicine RedefinedCOMPOUNDEDIN THE U.S.A.

    US board-certified physician review

    A board-certified physician builds your protocol.

    US-licensed 503A pharmacy

    Pharmaceutical-grade purity, prescribed by your physician.

    Shipped discreetly to your door

    Subscription billed monthly. Cancel anytime.

    How BPC-157 works

    BPC-157 is a 15-amino-acid peptide, modeled on a protein found in gastric juice, that has been studied for its role in tissue repair signaling.

    BPC-157 (Body Protection Compound-157) is a synthetic sequence of 15 amino acids modeled on a fragment of a protective protein found in human gastric juice. The compounded injectable uses the acetate form of the peptide, delivered subcutaneously.

    In preclinical research, BPC-157 has been studied for its effects on angiogenesis (the formation of new blood vessels), growth factor expression, and the migration of the cells involved in repairing tendon, ligament, and muscle tissue. The same body of research has examined its effects on the lining of the gut.

    Why BPC-157

    BPC-157 is one of the most discussed recovery peptides among men who train seriously, and for years it was available only through unregulated research-chemical sellers: no prescription, no physician, and no pharmacy standards behind the vial.

    EdgeRx offers BPC-157 as a single-ingredient protocol, prescribed by a U.S. board-certified physician for you specifically and compounded by a licensed U.S. 503A pharmacy from documented pharmaceutical-grade ingredients. No blends, no stacks, no mystery vials.

    What to expect

    BPC-157 is typically run as a daily subcutaneous protocol over several weeks. Because human data is limited, your physician sets expectations with you based on your goals and history rather than a fixed timeline.

    • A short daily routine with an insulin-sized needle
    • A patient-specific prescription with physician oversight throughout
    • Cold-chain shipping from the compounding pharmacy to your door
    • Clear guidance on storage, handling, and what to report

    How you take it

    The routine

    A small subcutaneous injection, typically once daily, with an insulin-sized needle. Most men take it at the same time each day.

    Starting dose

    Set by your prescribing physician after your medical assessment.

    Storage

    Refrigerated. Ships cold-chain from the pharmacy; keep it in the refrigerator and follow the beyond-use date on the label.

    Cycle length

    Typically run in courses of several weeks, with your physician deciding whether and when to repeat.

    Questions

    BPC-157 is a synthetic peptide of 15 amino acids, modeled on a fragment of a protective protein found in human gastric juice. It has been studied, mostly in animal and cell models, for its effects on the signaling involved in repairing tendon, ligament, muscle, and gut tissue. On EdgeRx it is compounded as a single-ingredient subcutaneous injection.

    No. BPC-157 is not an FDA-approved drug and has not been evaluated by the FDA for safety or effectiveness. The EdgeRx protocol is a compounded drug product prepared by a licensed U.S. 503A pharmacy for an individual patient on the basis of a physician's prescription. Compounded drug products are not reviewed or approved by the FDA.

    Same compound, two routes. The injection delivers BPC-157 subcutaneously and ships refrigerated. The tablet is a chewable liposomal formulation that ships at room temperature. Both are single-ingredient protocols; your physician helps you choose based on your goals and routine.

    They are separate protocols. EdgeRx does not offer blended or combined peptide products, and each protocol is prescribed on its own. Disclose everything you take during your medical assessment so your physician can build a protocol that is appropriate for you.

    Yes. BPC-157 on EdgeRx is prescribed by a U.S. board-certified physician after a medical assessment, for you specifically, and compounded by a licensed U.S. 503A pharmacy. Sites that sell BPC-157 without a prescription are selling research chemicals, not a compounded medication, with no physician, no pharmacy standards, and no accountability for what is in the vial.

    We have not set a launch date. Join the waitlist on this page and we will email you when ordering opens for BPC-157 specifically. We only email you about the protocols you asked about, and you can unsubscribe at any time.

    Join the BPC-157 waitlist

    The BPC-157 protocol will soon be available for purchase.

    Join the waitlist and we'll email you when ordering opens.

    Unsubscribe at any time.

    BPC-157 is not an FDA-approved drug and has not been evaluated by the FDA for safety or effectiveness. On EdgeRx it is prepared as a single-ingredient compounded drug product by a licensed U.S. 503A compounding pharmacy for an individual patient on the basis of a physician's prescription. Compounded drug products are not reviewed or approved by the FDA. Most published research on this compound comes from animal and cell studies, and controlled human trials are limited. This page describes the compound and how the EdgeRx protocol is structured; it does not claim that BPC-157 treats, cures, or prevents any disease. Tell your physician about every medication, supplement, and diagnosis before starting any protocol.